Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
出版年份 2020 全文链接
标题
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-12-03
DOI
10.3389/fphar.2020.603926
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of a promising agent IQZ23 for the treatment of obesity and related metabolic disorders
- (2020) Yong Rao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges
- (2020) Sander Lefere et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
- (2020) Nadine Gehrke et al. GASTROENTEROLOGY
- The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice
- (2020) Sarah A Marshall et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease
- (2020) Leonard Kaps et al. United European Gastroenterology Journal
- Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
- (2020) Benoit Smeuninx et al. Cancers
- Metabolism-Associated Molecular Patterns (MAMPs)
- (2020) Xu Wang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
- (2019) Lili Niu et al. Molecular Systems Biology
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- Bouchardatine analogue alleviates NAFLD/NASH in high fat fed mice via blunting ATP synthase activity
- (2019) Yong Rao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
- (2019) Tenagne D Challa et al. EMBO Molecular Medicine
- Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease
- (2019) Chiara Rosso et al. JOURNAL OF HEPATOLOGY
- Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation
- (2019) Fei Chen et al. HEPATOLOGY
- Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
- (2019) Michelle L Boland et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
- (2019) Meng Jiang et al. Frontiers in Endocrinology
- Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism
- (2019) Sophie A. Montandon et al. Scientific Reports
- Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
- (2019) Mitchel Tate et al. Frontiers in Physiology
- Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany
- (2019) Christian Labenz et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid: towards first approval for NASH
- (2019) Mohammed Eslam et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
- (2019) Sam Pearson et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- More Evidence for the Genetic Susceptibility of Mexicans Population to Nonalcoholic Fatty Liver Disease through PNPLA3
- (2018) Paulina Chinchilla-López et al. Annals of Hepatology
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease
- (2018) Cynthia Lebeaupin et al. JOURNAL OF HEPATOLOGY
- A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
- (2018) Takuma Tsuchida et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study
- (2018) Martine C. Morrison et al. Frontiers in Physiology
- Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
- (2018) Yuji Ogawa et al. Scientific Reports
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
- (2018) Mark A. Febbraio et al. Cell Metabolism
- Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation
- (2018) Yvonne Huber et al. Clinical Gastroenterology and Hepatology
- Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH
- (2018) Geoff Farrell et al. HEPATOLOGY
- BET Inhibition Improves NASH and Liver Fibrosis
- (2018) Sarah A. Middleton et al. Scientific Reports
- Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy
- (2018) Li Zhang et al. Frontiers in Pharmacology
- Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice
- (2017) Xue Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic
- (2017) Iliana Doycheva et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
- (2017) Shabnam Shalapour et al. NATURE
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex
- (2017) So Yeon Kim et al. Nature Communications
- Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population
- (2017) Ren-Nan Feng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Adipocyte lipolysis and insulin resistance
- (2016) Pauline Morigny et al. BIOCHIMIE
- Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine
- (2016) Norihiro Kishida et al. BMC GASTROENTEROLOGY
- The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease
- (2016) Nidhi P. Goyal et al. Clinics in Liver Disease
- Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
- (2016) Samir Softic et al. DIGESTIVE DISEASES AND SCIENCES
- Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model
- (2016) Kazuki Orime et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease
- (2016) Veeral Ajmera et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The Natural Course of Non-Alcoholic Fatty Liver Disease
- (2016) Luis Calzadilla Bertot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice
- (2016) Fahrettin Haczeyni et al. Obesity
- Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective
- (2016) Tommaso Mello et al. Oxidative Medicine and Cellular Longevity
- Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review
- (2016) Tyler J Severson et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy
- (2016) Rosa S. Kim et al. Scientific Reports
- Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice
- (2015) Shufei Zang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
- (2015) S. Rolla et al. CLINICAL SCIENCE
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity
- (2015) P Mulder et al. INTERNATIONAL JOURNAL OF OBESITY
- Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment
- (2015) Yong Rao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
- (2015) Mariana Verdelho Machado et al. PLoS One
- Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis
- (2015) Robert Schierwagen et al. Scientific Reports
- Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
- (2014) Yang Jiao et al. ACTA PHARMACOLOGICA SINICA
- CCl4 induced genotoxicity and DNA oxidative damages in rats: hepatoprotective effect of Sonchus arvensis
- (2014) Huda Mohammad Alkreathy et al. BMC Complementary and Alternative Medicine
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
- (2014) Hayato Nakagawa et al. CANCER CELL
- Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance
- (2014) Sarah M. Turpin et al. Cell Metabolism
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects
- (2014) Rémy Hanf et al. Diabetes & Vascular Disease Research
- Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects
- (2014) Ravirajsinh Jadeja et al. Evidence-based Complementary and Alternative Medicine
- Pnpla3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
- (2014) Eriks Smagris et al. HEPATOLOGY
- Inflammation, Obesity, and Metabolic Syndrome in Depression
- (2014) Chad D. Rethorst et al. JOURNAL OF CLINICAL PSYCHIATRY
- Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
- (2014) Yadong Huang et al. NEUROBIOLOGY OF DISEASE
- Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
- (2014) Salvatore Petta et al. PLoS One
- TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
- (2014) H. Mahdessian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
- (2013) Jason R. Clapper et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
- (2013) Victoria L. Gadd et al. HEPATOLOGY
- Lean NASH: distinctiveness and clinical implication
- (2013) Kausik Das et al. Hepatology International
- ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice
- (2013) Guozhi Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
- (2013) Masato Fujii et al. Medical Molecular Morphology
- The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease
- (2013) April D. Lake et al. TOXICOLOGICAL SCIENCES
- PNPLA3 I148M polymorphism and progressive liver disease
- (2013) Paola Dongiovanni WORLD JOURNAL OF GASTROENTEROLOGY
- Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
- (2013) Matthew J Armstrong et al. BMJ Open
- Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
- (2013) Carly Eckard et al. Therapeutic Advances in Gastroenterology
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
- (2012) Kouichi Miura et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Alstrom Syndrome: Genetics and Clinical Overview
- (2012) Jan D. Marshall et al. CURRENT GENOMICS
- Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
- (2012) Faidon Magkos et al. GASTROENTEROLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats
- (2012) Naoki Kumashiro et al. HEPATOLOGY
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010
- (2012) Jean A. Welsh et al. JOURNAL OF PEDIATRICS
- Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
- (2011) Michael Charlton et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- ASH and NASH
- (2011) F. Scaglioni et al. DIGESTIVE DISEASES
- Constitutive Role for IRE1α-XBP1 Signaling Pathway in the Insulin-Mediated Hepatic Lipogenic Program
- (2011) Jie Ning et al. ENDOCRINOLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
- (2011) Vlad Ratziu et al. HEPATOLOGY
- Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
- (2011) Timea Csak et al. HEPATOLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- (2011) Romina Lomonaco et al. HEPATOLOGY
- Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet
- (2011) Viviane Trak-Smayra et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Free fatty acids induce transglutaminase 2-dependent apoptosis in hepatocytes via ER stress-stimulated PERK pathways
- (2011) Ting-Fang Kuo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet
- (2011) Guohua Song et al. Lipids in Health and Disease
- Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption
- (2010) Jaimie N Davis et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease
- (2010) Russell K. Soon et al. GASTROENTEROLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis
- (2010) Rohit Kohli et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis
- (2010) Francisco Caballero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis
- (2009) Sander S. Rensen et al. AMERICAN JOURNAL OF PATHOLOGY
- Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet
- (2009) Sean W. P. Koppe et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Prevention of Steatosis by Hepatic JNK1
- (2009) Guadalupe Sabio et al. Cell Metabolism
- Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease
- (2009) Kazuto Tajiri et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats
- (2009) Manuela Aragno et al. FREE RADICAL BIOLOGY AND MEDICINE
- Heritability of Nonalcoholic Fatty Liver Disease
- (2009) Jeffrey B. Schwimmer et al. GASTROENTEROLOGY
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity
- (2009) Marie A. Hildebrandt et al. GASTROENTEROLOGY
- Non-Alcoholic Fatty Liver Disease in Older People
- (2009) James Frith et al. GERONTOLOGY
- The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
- (2009) A E Feldstein et al. GUT
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Kupffer cells in non-alcoholic fatty liver disease: The emerging view
- (2009) György Baffy JOURNAL OF HEPATOLOGY
- Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: A study in monozygotic and dizygotic twins
- (2009) Janne Makkonen et al. JOURNAL OF HEPATOLOGY
- Choline: an essential nutrient for public health
- (2009) Steven H Zeisel et al. NUTRITION REVIEWS
- Nitric Oxide Plays a Crucial Role in the Development/Progression of Nonalcoholic Steatohepatitis in the Choline-Deficient, l-Amino Acid-Defined Diet-Fed Rat Model
- (2008) Koji Fujita et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Gene expression in human NAFLD
- (2008) Dario Greco et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Association of Apolipoprotein E Polymorphisms in Patients with Non-Alcoholic Steatohepatitis
- (2008) Ali Sazci et al. DIGESTIVE DISEASES AND SCIENCES
- The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet
- (2008) Matthew Wortham et al. DIGESTIVE DISEASES AND SCIENCES
- Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
- (2008) Shuqin Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Toll‐like receptors and adaptor molecules in liver disease: Update
- (2008) Ekihiro Seki et al. HEPATOLOGY
- Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
- (2008) W. Ray Kim et al. HEPATOLOGY
- Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats
- (2008) Yan Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
- (2008) Mary E. Rinella et al. JOURNAL OF LIPID RESEARCH
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
- (2007) Puneet Puri et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation